財務情報
- Market Capitalization 4.87 B
- Employee 258
- Founded 2014
- CEO N/A
- Website www.cogentbio.com
- Headquarter Delaware, United States
- FIGI BBG007DHZQR7
- Industry 生物工学
総売上高
当期純利益
1株当たり基本利益(基本EPS)
有利子負債合計
フリーキャッシュフロー
現金および現金同等物
株価収益率
-16.44
売上高対価格比率
-637.59
関連ティッカー
| # | 名前 | 価格 | 24時間% | 7日% | 1か月% | 1年% | 時価総額 | 過去7日 | |
|---|---|---|---|---|---|---|---|---|---|
| 1309 | SRRK Scholar Rock Holding Corporation - Common Stock | 40.52 USD | -3.39% | -4.16% | -19.60% | +34.98% | 4.93 B USD | ||
| 1314 | TVTX Travere Therapeutics, Inc. - Common Stock | 51.80 USD | -0.42% | -6.52% | -20.70% | +80.05% | 4.88 B USD | ||
| 1321 | CRSP CRISPR Therapeutics AG - Common Shares | 50.10 USD | -2.81% | -5.47% | -4.70% | -28.48% | 4.84 B USD | ||
| 1357 | DFTX Definium Therapeutics, Inc. - Common Shares | 34.38 USD | -2.33% | -2.72% | -14.50% | +127.53% | 4.62 B USD |